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ABSTRACT 
 
 
Endogenous fluorescence lifetime imaging microscopy (FLIM) provides a 
nondestructive means to interrogate the biochemical composition of biological tissues. 
Therefore, it has the potential to identify tissue pre-malignant and malignant 
transformation. In this study, we evaluate the potential of endogenous FLIM for 
detecting benign oral lesions from pre-malignant and malignant oral lesions. Using a 
database of FLIM images (n=20) obtained in vivo from the oral cavity of patients 
undergoing tissue biopsy, we were able to identify specific features from the 
characteristic FLIM signal of benign, mild dysplastic, and cancerous oral lesions. These 
features were used to train statistical classification rules aimed to detect benign lesions 
from either dysplastic and cancerous lesions. Our results indicated that dysplastic and 
cancerous lesions could be detected from benign lesions with sensitivity of ~89% and 
specificity of ~95%. Our future efforts are focused on further developing our 
classification algorithms with additional FLIM in vivo data. 
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1. INTRODUCTION  
 
The autofluorescence imaging and spectroscopy can probe alternations noninvasively 
that occur during malignant process [1]. Fluorescence that comes from epithelial tissue is 
resulted from multiple fluorophores and affected by scattering and absorption as light 
propagates through the stroma and epithelium [2-4]. Reduced form of nicotinamide 
adenine dinucleotide (NADH) and mitochondrial metabolic coenzymes flavin adenine 
dinucleotide (FAD) have been known as the major sources of fluorescence in the 
epithelial layer. Collagen cross-links are the main source of autofluorescence in the 
underlying stroma. In normal oral epithelial tissue, stromal collagen is the major source 
of fluorescence, although there is also epithelial fluorescence. As dysplasia and 
malignancy developing, epithelial NADH/FAD fluorescence increases, while collagen 
fluorescence decreases. On the other hand, benign inflammation appears a decrease in 
both stromal collagen and epithelial NADH/FAD fluorescence. Bright fluorescence can 
also be found from the keratinized, superficial epithelial layer, which is often shown in 
normal oral tissue from specific anatomic sites such as the palate and the gingiva, as well 
as in clinically apparent leukoplakia. Furthermore, endogenous porphyrin fluorescence 
has been related to oral epithelial malignancy, although its accumulation is considered to 
be the result of microbial synthesis [5, 6].  
 
Steady-state wide-field imaging and fluorescence point-spectroscopy have been 
researched for the clinical diagnosis of oral epithelial cancer. In point-spectroscopy, a 
 2 
 
localized area of the tissue is explained with a single or multiple excitation wavelengths 
and the fluorescence emission is resolved over a broad spectral range. Novel fiber-probe 
designs have been developed for depth-sensitive fluorescence spectroscopy. Although it 
has a relatively rich signal, detection of benign from (pre)malignant oral lesions through 
fluorescence spectroscopy was not fully researched. Moreover, because of its 
interrogation area and limited spatial resolution, it is impractical for screening large 
areas of the oral mucosa. In wide-field imaging, the tissue is explained with a single 
excitation wavelength and the fluorescence emission is pictured over a single broad 
emission band. Thanks to its capability for real-time screening large areas, wide-field 
fluorescence imaging is already being applied on commercially and clinically available. 
Unfortunately, several studies have contradicted its utility as an adjunct tool for early 
diagnosis and screening because of its reported low specificity. There are some key 
factors that explain its lack of specificity: Subjectivity in its interpretation and limited 
characterization of the fluorescence. Objective interpretation based on image processing 
and multispectral imaging has been recently argued to address these problems, although 
we need to assess its utility [7, 8]. Many other reasons may explain why various steady-
state fluorescence imaging/spectroscopy studies have been so far inconclusive. For 
example, since steady-state fluorescence imaging/spectroscopy are based on relative or 
absolute fluorescence intensity measurements, they are sensitive to experimental 
artifacts which are hard to control during clinical interventions, and other factors not 
associated with dysplastic process (i.e. hyperplasia, keratinization, and blood optical 
interference) [9-11]. 
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On the other hand, fluorescence lifetime measurements are less sensitive to such artifacts 
which means more robust for clinical applications [12]. In addition, since most 
endogenous fluorophores have broad emission bands, tissue characterization based on 
only spectral/intensity changes may be hard to get sufficient accuracy for clinical 
detection. However, fluorescence lifetime can resolve fluorophores with heavily 
overlapping spectra [13]. In particular, fluorescence from NADH and collagen has 
overlapping emission spectra and same excitation maximum, but very distinct 
fluorescence lifetimes. Furthermore, fluorescence lifetime is sensitive to alternations in 
cellular physiology [13]. In particular, the relative concentration of the free and bound 
forms of both FAD and NADH are associated with the metabolic state of the tissue; thus, 
providing additional means for detecting highly active precancerous tissue. While the 
free and bound forms of NADH have virtually the same absorption and emission spectra 
(the same applies for FAD), they show very distinct fluorescence lifetimes [14]. Thus, 
differences in tissue fluorescence resulting from compositional, morphological and 
functional transformations related to (pre)malignancy would be more accurately 
quantified based on fluorescence lifetime measurements. 
 
In spite of its significant advantages, fluorescence lifetimes measurements have not been 
extensively evaluated for the detection of oral (pre)malignancy. Wang et al. performed 
in vivo autofluorescence TRFS measurements at ~630 nm upon 408 nm excitation in 
patients with suspicious (pre)malignant lesions and reported that dysplastic lesions could 
be found from benign lesions (both epithelial hyperplasia and verrucous) with 75% 
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specificity and 93% sensitivity on a small database of 38 lesions [15]. Marcu et al. 
performed in vivo fluorescence TRFS measurements in the spectral range of 360-650 nm 
upon 337 nm excitation in the hamster cheek-pouch model and found three fluorescence 
emission peaks with distinct lifetimes at ~390 nm, 460 nm and 635 nm, which were 
related to collagen, NADH and porphryrin. In addition, they reported that normal 
epithelium could be identified from (pre)malignant lesions with 100% specificity and 
sensitivity, though their database did not include benign lesions. Even if these two pilot 
studies have been encouraging, point-spectroscopy is impractical for screening large 
areas of the oral mucosa. Skala et al. experimented endogenous multiphoton FLIM in a 
hamster model of oral cancer [16]. Their results showed a decrease in bound NADH 
lifetimes with dysplasia consistent with neoplastic metabolism. In a subsequent study, 
they reported an increase in bound FAD lifetime with dysplasia, reflecting a reduction in 
intracellular NAD+ expected with malignancy [17]. Though multiphoton FLIM 
microscopy gives extremely high spatial resolution both axially and laterally, it has very 
limited field of view and intrinsically slow acquisition speed. Marcu et al. reported a 
flexible endoscope that was used to collect 26 endogenous FLIM images from tumors 
and surrounding normal tissue in 10 patients undergoing head and neck surgery [18]. 
They observed that tumor areas appeared significantly shorter fluorescence lifetime 
values and weaker fluorescence intensity, compared to normal areas; however, 
histopathology was not used as the gold standard and the acquisition time of their 
instrument was too long.  
 5 
 
The ultimate goal of this research is to validate and develop a novel imaging clinical tool 
that acquires and processes multispectral FLIM images of the oral mucosa in vivo and in 
real time for noninvasive real-time detection of precancerous and cancerous lesions. One 
key specific aim of this research is to develop algorithms for automated in vivo detection 
of oral precancer and cancer based on FLIM imaging, which was the focus of this thesis. 
This work represents the first demonstration of endogenous FLIM endoscopic imaging 
for automated detection of a wide range of oral benign lesions (including inflammation) 
from oral pre-cancerous (mild-dysplasia) and cancerous (squamous cell carcinoma, SCC) 
lesions. 
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2. METHOD 
 
2.1 Multispectral FLIM endoscope [19]  
The system consisted of a handheld box fitted with a custom-designed rigid endoscope, 
as shown in Figure 1 (a). The schematic of the FLIM endoscopy system is shown in 
Figure 1 (b). A frequency-tripled Q-switched Nd:YAG laser is applied as the excitation 
source. The excitation fiber core diameter and the objective lens focal length determine 
the lateral resolution (~100 um) and the field of view (FOV=11 mm diameter) of the 
system. The fluorescence emission is separated by a dichroic mirror (DM1) and then 
collected by a multimode fiber (200 µm core diameter), which delivers the emission to a 
multispectral detection unit outside of the handheld box. In this unit, a set of filters (F1-
F3) and dichroic mirrors (DM2, DM3) separate the emission into multiple spectral bands, 
each one coupled into separate multimode fibers of different lengths that give an optical 
delay between each spectral band. Therefore, for a single excitation pulse, a single 
detector can be used for recording multiple decays corresponding to different spectral 
bands. The spectral bands can be divided based on the targeted fluorophores. We chose 
the 390±20 nm, 452±22.5 nm, and >500 nm bands to distinguish emission from three 
tissue endogenous fluorophores: collagen, NADH, and FAD, respectively. The 
multispectral fluorescence signal is observed by a multichannel plate photomultiplier 
tube (MCP-PMT, 25 ps TTS), followed by a preamplifier before being digitized at 6.25 
GS/s. The multispectral FLIM data is composed of three fluorescence decays per pixel 
(one per emission band). After temporal deconvolution of the instrument response from 
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the measured fluorescence decay, nine images were made to quantify the fluorescence 
emission of the samples (Figure 2): absolute integrated fluorescence intensity (I1, I2 and 
I3), normalized integrated fluorescence intensity  (
I1
(I1+I2+I3)
, 
I2
(I1+I2+I3)
, 
I3
(I1+I2+I3)
)  and 
average lifetime maps for each of the three emission bands. The average lifetime was 
calculated via 𝜏𝑎𝑣𝑒 =
∑th(t)
∑h(t)
, where h(t) is the deconvolved fluorescence temporal decay 
at a given pixel, and t is the time vector.  
 
 
 
 
Figure 1   Photograph and schematic of the FLIM endoscopy system. (a) Photograph of 
the handheld rigid endoscope; (b) Schematic of the multispectral FLIM rigid 
endoscope system. DM: Dichroic mirror, L: Lens, F: Filter. 
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Figure 2 In vivo imaging of a dysplasia lesion. (a) Absolute fluorescence intensity maps; 
(b) Normalized fluorescence intensity maps; (c) Fluorescence lifetime maps. 
 
 
 
2.2 In vivo imaging  
A total of 20 patients undergoing tissue biopsy of suspicious lesions were recruited. The 
imaging protocol was approved by the Institutional Review Board at Texas A&M 
University and Baylor College of Dentistry. Prior to biopsy sample resection, the 
physician took a multispectral FLIM image from the clinical oral lesion with our 
endoscope. An additional multispectral FLIM image was acquired from a normal area on 
the contralateral side. The acquisition time was less than 2 seconds per image. The 
biopsy samples were then resected following standard procedures. 
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2.3 FLIM data processing 
 
 
 
 
Figure 3 Composition of FLIM data. (a) Actual FLIM data; (b) Actual signals of a 
pixel. 
 
 
 
In a FLIM image, the fluorescence intensity generated at each pixel (x,y) is measured as 
a function of different emission wavelengths or spectral bands (λ) and a function of time 
(t), as depicted in Figure 3. The spectral bands can be divided based on the targeted 
fluorophores. We chose the 390±20 nm, 452±22.5 nm, and >500 nm bands to distinguish 
emission from three tissue endogenous fluorophores: collagen, NADH, and FAD, 
respectively. The signals of the three channels in a pixel are visualized in Figure 3 (b). 
I(x, y, λ, t) indicates that each intensity is determined by the pixel’s location (x, y), 
wavelength (λ), and time (t). Figure 4 is an enlarged figure that is similar to Figure 3 (b) 
with real measured data. 
 
(b) 
(a) 
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Figure 4 Enlarged actual signals of a pixel in FLIM data. 
 
 
 
In the time-domain FLIM acquisition, the measured decay at a given pixel of the FLIM 
image represents the convolution of the instrument response with the fluorescence 
Impulse Response Function (IRF) of the sample at that pixel. Therefore, we need to 
implement a deconvolution procedure to estimate the real fluorescence decay. We use 
the previously reported Laguerre FLIM deconvolution algorithm [20] to estimate the 
intrinsic fluorescence decays at each pixel. Typically, the fluorescence decay y(n) is 
given by the convolution of the IRF h(n) with the instrument response x(n): 𝑦(𝑛) = 𝑇 ∙
∑ ℎ(𝑚)𝑥(𝑛 − 𝑚),   𝑛 = 0,1, … , 𝑁 − 1 𝐾−1𝑚=0 , where T is the sampling interval, N is the 
number of measured samples, and K determines the time length of the IRF [21]. The 
Laguerre deconvolution technique uses a set of discrete Laguerre functions (DLF) as an 
orthonormal basis to represent IRF: ℎ(𝑛) = 𝑇 ∙ ∑ 𝑐𝑗
𝛼𝑏𝑗
𝛼(𝑛)𝐿−1𝑗=0 , where 𝑐𝑗
𝛼  are the 
Laguerre Coefficients (LC), which are to be estimated from the input-output data, 𝑏𝑗
𝛼 
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denotes the j-th order orthonormal DLF, and L is the number DLFs used to model the 
IRF[21]. The Laguerre parameter α determines the rate of asymptotic decline of the 
DLFs. The larger the α, the longer a DLF is spread over time. For a given pixel, the 
measured fluorescence decay y(n) can thus be written as: 𝑦(𝑛) = ∑ 𝑐𝑗
𝛼𝑣𝑗
𝛼(𝑛)𝐿−1𝑗=0 , where: 
𝑣𝑗
𝛼(𝑛) = ∑ 𝑏𝑗
𝛼(𝑚)𝑥(𝑛 − 𝑚)𝐾−1𝑚=0 . After applying the Laguerre FLIM deconvolution 
algorithm, three deconvolved decays (ℎ1(𝑡), ℎ2(𝑡), ℎ3(𝑡)) are acquired per pixel, each 
corresponding to the three emission bands described above. Figure 5 shows the 
deconvolved decays of a sample pixel. The decay profiles (h(t)) at each pixel are 
integrated to generate absolute fluorescence intensity maps corresponding to each 
wavelength band (I1, I2 and I3). The normalized intensities (In) are calculated at each 
pixel as: In1 =
𝐼1
𝐼1+𝐼2+𝐼3
, In2 =
𝐼2
𝐼1+𝐼2+𝐼3
 and In3 =
𝐼3
𝐼1+𝐼2+𝐼3
. The average fluorescence 
lifetime (dlifetime) and 
1
𝑒
 lifetime (dtau) for each pixel are calculated using their general 
mathematical definitions [22]. Thus, the FLIM processing results in a set normalized 
intensity, average lifetime and 1/e lifetime maps, as shown in Figure 6 for a sample 
FLIM data set. 
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Figure 5 Deconvolved fluorescence decays. 
 
 
 
 
Figure 6  Final results of FLIM data processing. “In” means normalized intensity map, 
“dlifetime” means average lifetime map, and “dtau” means 
𝟏
𝒆
 lifetime map. The 
number after In, dlifetime, and dtau indicates the channel number. 
 
 
 
2.4 Feature pre-selection  
The nine FLIM parameters estimated at each pixel of the image (as shown in Figure 6), 
represents FLIM features that can potentially be used for classifying the different types 
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of oral lesions, in particular: benign lesions (B), from pre-cancerous or dysplastic lesions 
(D) and squamous cell carcinomas (S). As a first approach, we used the pixel median 
value of each of these FLIM parameters as classification features. In order to identify 
those features useful for classification, we plotted the median FLIM parameter value of 
each lesion (Disease red markers) and its contralateral imaged side (Normal blue 
markers), as in Figure 7.  
 
The data from the gingiva lesions are shown in Figure 7(a). It can be observed that the 
median value for In1 is virtually the same for the benign lesions and its corresponding 
contralateral normal area, while the cancerous lesions showed smaller median In1 values 
with respect to its corresponding contralateral normal area. It can also be observed that 
the median value for In3 is virtually the same for the benign lesions and its 
corresponding contralateral normal area, while the cancerous lesions showed larger 
median In3 values with respect to its corresponding contralateral normal area. Thus, two 
features were selected for classifying benign from cancerous gingival lesions: 1) 
difference in In1 between lesion and contralateral normal side, 2) difference in In3 
between lesion and contralateral normal side. 
 
The data from the tongue lesions are shown in Figure 7(b). It can be observed that the 
median value for In3 for the cancerous lesions was higher than for most benign and 
dysplastic lesions. It can also be observed that the median value for In3 is virtually the 
same for the benign lesions and its corresponding contralateral normal area, while most 
 14 
 
dysplastic and cancerous lesions showed larger median In3 values with respect to its 
corresponding contralateral normal area. It can also be observed that the median value 
for dlifetime1, dlifetime2 and dtau2 is virtually the same for the benign lesions and its 
corresponding contralateral normal area, while most dysplastic and cancerous lesions 
showed smaller median values with respect to its corresponding contralateral normal 
area. Thus, five features were selected for classifying benign from cancerous tongue 
lesions: 1) In3, 2) difference in In3 between lesion and contralateral normal side, 3) 
difference in dlifetime1 between lesion and contralateral normal side, 4) difference in 
dlifetime2 between lesion and contralateral normal side, and 5) difference in dtau2 
between lesion and contralateral normal side. 
 
 
 
 
Figure 7 Median plots from gingiva and tongue. (a) Median plot of gingiva datasets. B 
indicates benign and S indicates SCC; (b) Median plot of tongue datasets. B 
indicates benign, D indicates dysplasia, and S means SCC. 
(a) 
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Figure 7 Continued. 
 
 
 
In summary, based on these observations, a total of six FLIM parameters were pre-
selected as potential discriminatory features for classifying benign from pre-cancerous 
and cancerous lesions. 
 
2.5 Classification problems  
The main objective of this work was to develop classification algorithms aiming to 
discriminate benign lesions from either pre-cancerous or cancerous lesions, based on 
FLIM derived features. For this purpose, we defined three classification problems: 1) 
benign vs. cancerous gingiva lesions; 2) benign vs. dysplastic/cancerous tongue lesions; 
and 3) benign vs. dysplastic/cancerous gingiva and tongue lesions. 
 
(b) 
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2.6 Feature selection  
Starting from the six pre-selected FLIM based features, exhaustive searching [23] was 
applied to find an optimal subset of features for each classification problem. Exhaustive 
searching is a feature selection method that explores the entire search space by testing all 
possible candidate solution. If we have n candidates and want to find the best set with 
size k, the number of subsets to be evaluated is (𝑛
𝑘
). This shows that the number of 
iterations can be huge even for modest n and k. In our case, however, there were only six 
candidates to be considered; thus, the cost of exhaustive searching is low.  
 
2.7 Classification algorithms  
For evaluating each feature subset, we need classification rules to estimate the error. In 
this study, three different classification rules were considered: Linear Discriminant 
Analysis (LDA), 3-Nearest-Neighbor (3NN), and Support Vector Machines (SVM). 
They are described below.  
 
2.7.1 Linear Discriminant Analysis (LDA) [23]  
LDA is a method for finding a linear combination of features that separates data into a 
number of classes (two classes for our classification problems). The designed classifier 
is derived as 
φ𝑛(𝑥) = {
1,    𝑎𝑛
𝑇𝑥 + 𝑏𝑛 >  0 
0,     𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒         
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where 𝑎𝑛 = ∑̂
−1  ∙ (𝑢1 − 𝑢0),  𝑏𝑛 = −
1
2
(𝑢1 − 𝑢0)
𝑇 ∙ ∑̂ −1 ∙ (𝑢1 + 𝑢0)  and x is the 
training feature vectors. In detail, ∑̂  denotes the single covariance matrix, which is 
estimated by the pooled sample covariance matrix and 𝑢1,  𝑢0 are the mean feature 
vectors in each group.  
 
2.7.2 3-Nearest-Neighbor (3NN) [23]  
3NN is a nonparametric method that estimates class-conditional densities without 
making any distributional densities. This algorithm uses the majority vote of its 
neighbors. In other words, the class of an object is assigned to the most common class 
among its K-Nearest-Neighbor (KNN). It is a great way to assign weight to the 
contributions of the neighbors because nearer neighbors contribute more than distant 
ones. The parameter k must be changed according to the data. Larger k can reduce the 
effect of noise on the classification [24], while it produces less distinct boundaries 
between classes. In binary classification, it is helpful to choose k to be an odd number 
because of the case of tied votes. We considered k=1, 3, 5 and finally, 3-Nearest-
Neighbor shows the best result because of its good speed and accuracy. The designed 
classifier is derived as  
φ𝑛(𝑥) = {
1, ∑ 𝐼{𝑌𝑖=1}
3
𝑖=1
>  ∑ 𝐼{𝑌𝑖=0}
3
𝑖=1
 
0,   𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒                               
 
Here, x is the training feature vectors and y is the labels of that training feature vectors. 
φ𝑛(𝑥) is the designed classifier and 𝐼{𝑌𝑖=1} or 𝐼{𝑌𝑖=0} is the i-th nearest data point to x 
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that has the label 1 or label 0. Thus, the designed classifier will be 0 if the nearest 
neighbors of x have more 0 than 1 labels.  
 
2.7.3 Support Vector Machines (SVM) [23]  
SVM is a supervised learning model that analyzes data and recognizes patterns that is 
used for classification. This model separates two categories with a clear gap by making 
the gap as wide as possible. After that, data is mapped into that same space and predicted 
to belong to a category based on which side of the gap they fall into. The main reason 
why we employ this method is that SVM can perform non-linear classification using the 
kernel approach. In our study, we use linear and Gaussian kernels. The designed 
classifier by SVM with linear kernel is given by: 
φ𝑛(𝑥) = {
1, 𝑖𝑓 ∑ 𝜆𝑖
∗𝑦𝑖𝑥𝑖
𝑇𝑥 −
1
𝑛𝑠 
∑ ∑ 𝜆𝑖
∗𝑦𝑖𝑥𝑖
𝑇𝑥𝑗 +
1
𝑛𝑠
∑ 𝑦𝑖 > 0
𝑖∈𝑆𝑗∈𝑆𝑖∈𝑆𝑖∈𝑆
 
0,               𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒                                                                         
 
Here, φ𝑛(𝑥) is the designed classifier and 𝜆𝑖
∗  is the optimal Lagrange multiplier, which 
can be achieved from maximizing the dual Lagrange functional [23]. The set {(𝑥𝑖,
𝑦𝑖); 𝑖 ∈ 𝑆} is the set of support vector points, x is the training feature vectors, y is the 
labels of that training feature vectors (±1, instead of 0 and 1), and 𝑛𝑠 is the number of 
support vectors. The designed classifier by SVM with Gaussian kernel is given by: 
φ𝑛(𝑥) = {
1, 𝑖𝑓 ∑ 𝜆𝑖
∗𝑦𝑖𝑘(𝑥𝑖, 𝑥) −
1
𝑛𝑠 
∑ ∑ 𝜆𝑖
∗𝑦𝑖𝑘(𝑥𝑖, 𝑥𝑗) +
1
𝑛𝑠
∑ 𝑦𝑖 > 0
𝑖∈𝑆𝑗∈𝑆𝑖∈𝑆𝑖∈𝑆
0,               𝑜𝑡ℎ𝑒𝑟𝑤𝑖𝑠𝑒                                                                                      
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where 𝑘(𝑥𝑖 , 𝑥𝑗) is a kernel function, and we only employ the Gaussian kernel, which is 
𝑘(𝑥𝑖 , 𝑥𝑗) = exp (
−|x𝑖−𝑥𝑗|
2
𝜎2
).  
 
2.8 Performance quantification  
To estimate the error at the feature selection stage, the Leave-One-Out Cross Validation 
(LOO) method [23] was used. LOO is a model evaluation method for measuring how 
results of the classification analysis are generalized to an independent dataset. To 
achieve this, one of the datasets is removed before training. After training, the removed 
dataset is used to test the performance of the learned classifier. The main goal of LOO is 
to achieve unbiased estimation results and also, explain the model generalization in an 
independent dataset. 
 
For each classification problem, the training data consisted on the pixel median values of 
the FLIM features. Thus, for each lesion, we only have one training data. For LOO 
validation, we followed two approaches. For the first approach, denoted ‘sample 
classification’, the leave-out lesion was classified as a single sample based on the pixel 
median FLIM feature values. For the second approach, denoted ‘pixel classification’, 
each pixel of the leave-out lesion was classified based on each pixel FLIM feature values. 
The exhaustive feature search was performed based on the sample classification 
accuracy. In addition, the pixel classification performance was quantified in the LOO 
overall classification accuracy, and sensitive and specificity for classifying dysplastic or 
cancerous pixels. 
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3. RESULT  
 
3.1 Histopathology evaluation  
A total of 20 lesions were imaged, six from the gingiva, and the other 14 from the tongue. 
Table 1 shows a summary of histopathology distribution. To be specific, dysplasia 
means mild epithelial dysplasia and SCC means squamous cell carcinoma. All other 
pathological diagnoses are benign.  
 
 
 
 
Table 1 Summary of histopathology distribution. 
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3.2 Classification – Gingiva 
A total of six gingiva lesions were imaged, from which three were benign and three were 
cancerous. Starting from the six FLIM based featured pre-selected before, the exhaustive 
searching was applied to find the best feature set among all the combinations that would 
classify the benign from the cancerous lesions. Based on the exhaustive searching, an 
LDA classification rule with the following two features was identified as optimal: 1) 
difference in In1 between lesion and contralateral normal side, 2) difference in In3 
between lesion and contralateral normal side.  
 
Figure 8 is a scatter plot with the best features and classification rule for the gingiva 
classification. It shows that all datasets were correctly classified. Table 2 shows the LOO 
sample-level confusion matrix of the gingiva area, indicating that all samples were 
classified correctly. 
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Figure 8 Scatter plot based on gingiva training datasets. Blue dots are benign, and red 
dots are SCC. The X-axis is the first feature, and the Y-axis is the second 
feature used in the gingiva. The black line is a decision boundary from LDA 
that distinguishes benign from SCC. In this figure, LDA was trained with all 
samples for better visualization, even if we actually apply LOO at the feature 
selection stage. 
 
 
 
 
Table 2 LOO sample-level confusion matrix of gingiva area. 
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Next, we performed a pixel classification with the same features and classification rule 
as the sample classification. To achieve this, pixel median values of the FLIM features 
were used for training and each pixel value of FLIM feature from the leaved-out FLIM 
image was used for testing the trained classification rule. Figure 9 shows the 
classification maps derived from two selected features using the LDA classification rule. 
Table 3 shows the LOO pixel-level confusion matrix of the gingiva, indicating high 
sensitivity and very high specificity for cancer detection.  
 
 
 
 
Figure 9 Classification maps of gingiva. The green color means benign, the red color 
means SCC, and the blue color (mask) represents the portion excluded from 
the classification process. Benign should be mostly green, while SCC is 
mainly red. 
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Table 3 LOO pixel-level confusion matrix of gingiva area. It shows that sensitivity for 
SCC is 86.7%, while specificity for SCC is 98.7%. 
 
 
 
3.3 Classification – Tongue 
In tongue, 14 lesions were imaged, from which six were benign, four were precancerous, 
and four were cancerous. As in the gingiva, the exhaustive searching was used to find 
the best feature set among all the combinations of candidates that would distinguish 
benign from the precancerous and cancerous lesions. From the exhaustive searching, 
SVM Gaussian kernel with the following three features was determined as optimal: 1) 
difference in In3 between lesion and contralateral normal side, 2) In3, and 3) difference 
in dlifetime2 between lesion and contralateral normal side. 
 
Figure 10 is a scatter plot with the best features and classification rule of the tongue 
classification. It shows that all datasets were correctly distinguished. Table 4 shows the 
LOO sample-level confusion matrix of the tongue area, representing that all samples are 
classified perfectly. 
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Figure 10 Scatter plot based on tongue training datasets. Blue dots are benign, green 
dots are dysplasia, and red dots are SCC. Additionally, the black circles that 
surround the dots are support vectors. The X-axis is the first feature, the Y-
axis is the second feature, and the Z-axis is the third feature used in the 
tongue area. The black hyperplane is a decision boundary from SVM 
Gaussian kernel that distinguishes benign from dysplasia and SCC. In this 
figure, the classification rule was trained with all samples for better 
visualization, even if we actually apply LOO at the feature selection stage. 
 
 
 
 
Table 4 LOO sample-level confusion matrix of tongue area. 
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Next, we conducted a pixel classification with the same features and classification rule 
that were the best in the sample classification. As before, pixel median values of the 
FLIM features were applied for training and each pixel value of FLIM feature from the 
leaved-out FLIM image was applied for testing the trained classification rule. Figure 11 
shows the classification maps derived from three selected features using the SVM 
Gaussian kernel. Table 5 represents the LOO pixel-level confusion matrix of the tongue 
datasets, indicating high sensitivity and specificity for precancer and cancer detection. 
 
 
 
 
Figure 11 Classification maps of tongue. The green color means benign, the red color 
means Dysplasia/SCC, and the blue color (mask) shows the portion 
excluded from the classification procedure. Benign should be mainly green, 
while Dysplasia/SCC must be mostly red. 
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Table 5 LOO pixel-level confusion matrix of tongue area. It shows that sensitivity for 
Dysplasia/SCC is 93.2%, while specificity for Dysplasia/SCC is 90%. 
 
 
 
3.4 Classification – Gingiva and Tongue 
In the entire area, a total of 20 lesions were collected, from which nine were benign, four 
were precancerous, and seven were cancerous. Beginning from the six FLIM based 
featured pre-selected before, the exhaustive searching was applied to discover the best 
feature combination among all the combinations that would be helpful to classify the 
benign from the precancerous and cancerous lesions. Based on the exhaustive searching, 
SVM Gaussian kernel with the following three features were identified as optimal: 1) 
difference in In3 between lesion and contralateral normal side, 2) In3, and 3) difference 
in dlifetime2 between lesion and contralateral normal side. 
 
Figure 12 is a scatter plot with the best features and classification rule for the entire 
classification. It indicates that all datasets were well classified, except for one dysplasia. 
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Table 6 represents the LOO sample-level confusion matrix of the entire area, indicating 
that all samples were classified correctly, except for one dysplasia. 
 
 
 
 
Figure 12 Scatter plot based on total training datasets. Blue dots are benign, green dots 
are dysplasia, and red dots are SCC. In addition, the black circles that 
surround the dots are support vectors. The black hyperplane is a decision 
boundary from SVM Gaussian kernel that separates benign from dysplasia 
and SCC. In this figure, SVM Gaussian kernel was trained with all samples 
for better visualization, even if we actually apply LOO at the feature selection 
stage. 
 
 
 
 
Table 6 LOO sample-level confusion matrix of entire area. 
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As before, we performed a pixel classification with the same features and classification 
rule as the sample classification. To achieve this, pixel median values were used for 
training and each pixel value from the leaved-out FLIM image was applied for testing 
the trained classification rule. Figure 13 shows the classification maps resulted from 
three selected features using the SVM Gaussian kernel. Table 7 represents the LOO 
pixel-level confusion matrix of the entire datasets, showing high sensitivity and very 
high specificity for precancer and cancer detection. 
 
 
 
 
Figure 13 Classification maps of gingiva and tongue. The green color means benign, the 
red color means Dysplasia/SCC, and the blue color (mask) shows the portion 
excluded from the classification process. Benign should be mostly green, 
while Dysplasia/SCC is mainly red. 
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Table 7 LOO pixel-level confusion matrix of entire area. It shows sensitivity for 
Dysplasia/SCC is 85.7%, while specificity for Dysplasia/SCC is 97.1%. 
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4. CONCLUSIONS  
 
To the best of our knowledge, this is the first demonstration of endogenous FLIM 
endoscopic imaging for automated detection of a wide range of oral benign lesions 
(including inflammation) from oral pre-cancerous (mild-dysplasia) and cancerous (SCC) 
lesions. Our results indicate that both fluorescence intensity and fluorescence lifetime 
derived features are important in order to achieve decent lesion classification 
performance. Fluorescence lifetime was in particular relevant to distinguish pre-
cancerous lesions from benign lesions.  
 
We should recognize, however, that our current database is limited to a few lesions in 
the gingiva and tongue areas of the oral cavity, including the vestibule, palate and 
mucosa. However, our preliminary results are encouraging and our ongoing efforts are 
focused on further validating on a larger database this promising technology for early 
detection of oral epithelial cancer. 
 
 
 32 
 
REFERENCES 
 
[1] Ramanujam, N., Fluorescence spectroscopy of neoplastic and non-neoplastic 
tissues. Neoplasia, 2000. 2(1-2): p. 89-117. 
[2] Georgakoudi, I., Jacobson, B.C, Muller, M.G, Sheets, E.E, Badizadegan,K, et al., 
NAD(P)H and collagen as in vivo quantitative fluorescent biomarkers of 
epithelial precancerous changes. Cancer Research, 2002. 62(3): p. 682-7. 
[3] Wu, Y.C. and J.N.Y. Qu, Autofluorescence spectroscopy of epithelial tissues. 
Journal of Biomedical Optics, 2006. 11(5): 054023. 
[4] Pavlova, I., Williams, M., El-Naggar, A., Richards-Kortum, R., Gillenwater, A., 
Understanding the biological basis of autofluorescence imaging for oral cancer 
detection: high-resolution fluorescence microscopy in viable tissue. Clinical 
Cancer Research, 2008. 14(8): p. 2396-2404. 
[5] Harris, D.M. and J. Werkhaven, Endogenous porphyrin fluorescence in tumors. 
Lasers in Surgery and Medicine, 1987. 7(6): p. 467-472. 
[6] Betz, C.S., Mehlmann, M., Rick, K., Stepp, H., Grevers, G, et al., 
Autofluorescence imaging and spectroscopy of normal and malignant mucosa in 
patients with head and neck cancer. Lasers in Surgery and Medicine, 1999. 
25(4): p. 323-334. 
[7] Roblyer, D., Kurachi, C., Stepanek, V., Williams, M.D., El-Naggar, A.K., et al., 
Objective detection and delineation of oral neoplasia using autofluorescence 
imaging. Cancer Prevention Research, 2009. 2(5): p. 423-431. 
 33 
 
[8] Bedard, N., Schwarz, R.A., Hu, A., Bhattar, V., Howe, J., et al., Multimodal 
snapshot spectral imaging for oral cancer diagnostics: a pilot study. Biomedical 
Optics Express, 2013. 4(6): p. 938-949. 
[9] Lee, J.S.,Shuhatovich, O., Price, R., Pikkula, B., Follen, M., et al., Design and 
preliminary analysis of a study to assess intra-device and inter-device variability 
of fluorescence spectroscopy instruments for detecting cervical neoplasia. 
Gynecologic Oncology, 2005. 99(3 Suppl 1): p. S98-111. 
[10] Marin, N.M., MacKinnon, N., MacAulay, C., Chang, S.K., Atkinson, E.N., et al., 
Calibration standards for multicenter clinical trials of fluorescence spectroscopy 
for in vivo diagnosis. Journal of Biomedical Optics, 2006. 11(1): 014010. 
[11] Pikkula, B.M., Shuhatovich, O., Price, R.L., Serachitopol, D.M., Follen, M., et 
al., Instrumentation as a source of variability in the application of fluorescence 
spectroscopic devices for detecting cervical neoplasia. Journal of Biomedical 
Optics, 2007. 12(3): 034014. 
[12] Morgan, C.G. and A.C. Mitchell, Fluorescence lifetime imaging: an emerging 
technique in fluorescence microscopy. Chromosome Res, 1996. 4(4): p. 261-263. 
[13] Lakowicz, J.R., Principles of fluorescence spectroscopy. 2nd ed. 1999, New 
York: Kluwer Academic/Plenum Publishers. p. 95-140. 
[14] Ramanujan, V.K., Zhang, J.H., Biener, E., Herman, B., Multiphoton fluorescence 
lifetime contrast in deep tissue imaging: prospects in redox imaging and disease 
diagnosis. Journal of Biomedical Optics, 2005. 10(5): 051407. 
[15] Chen, H.M., Chiang, C.P., You, C., Hsiao, T.C., Wang, C.Y., et al., Time-resolved 
 34 
 
autofluorescence spectroscopy for classifying normal and premalignant oral 
tissues. Lasers in Surgery and Medicine, 2005. 37(1): p. 37-45. 
[16] Skala, M.C., Squirrell, J.M., Vrotsos, K.M., Eickhoff, J.C., Gendron-Fitzpatrick, 
A., et al., Multiphoton microscopy of endogenous fluorescence differentiates 
normal, precancerous, and cancerous squamous epithelial tissues. Cancer 
Research, 2005. 65(4): p. 1180-6. 
[17] Skala, M.C., Riching, K.M., Gendron-Fitzpatrick, A., Eickhoff, J., Eliceiri, K.W., 
et al., In vivo multiphoton microscopy of NADH and FAD redox states, 
fluorescence lifetimes, and cellular morphology in precancerous epithelia. 
Proceedings of the National Academy of Sciences, 2007. 104(49): p. 19494-
19499. 
[18] Sun, Y., Phipps, J.E., Meier, J., Hatami, N., Poirier, B., et al., Endoscopic 
fluorescence lifetime imaging for in vivo intraoperative diagnosis of oral 
carcinoma. Microscopy and Microanalysis, 2013. FirstView: p. 1-8. 
[19] Cheng, S., Cuenca, R.M., Liu, B., Malik B.H., Jabbour, J.M., et al., Handheld 
multispectral fluorescence lifetime imaging system for in vivo applications. 
Biomedical Optics Express, 2014. 5(3): p. 921-931. 
[20] Jo, J.A., Marcu, L., Fang, Q., Papaioannou, T., Qiao, J.H., et al., New methods for 
time-resolved fluorescence spectroscopy data analysis based on the laguerre 
expansion technique--applications in tissue diagnosis. Methods of Information in 
Medicine, 2007. 46(2): p. 206-11. 
[21] Jo, J.A., Fang, Q., and Marcu, L., Ultrafast method for the analysis of 
 35 
 
fluorescence lifetime imaging microscopy data based on the laguerre expansion 
technique. IEEE Journal of Quantum Electronics, 2005. 11(4): p. 835-845. 
[22] Lakowicz, J.R., Principles of fluorescence spectroscopy. Chemistry in Britain, 
1984. 20(5): p. 442-442. 
[23] Duda, R.O., Hart, P.E.,  and Stork, D.G., Pattern classification. 2nd ed. 2001, 
New York: Wiley. xx, p. 654. 
[24]      Everitt, B.S., Landau, S., Leese, M., and Stahl, D., Cluster analysis. 5th ed. 2011, 
Chichester, West Sussex, U.K.: Wiley. xii, p. 330. 
